{
    "code": 0,
    "data": [
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December 2025.",
            "news_id": "7958ebf6-0dda-462f-97de-e9586cb22057",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cac5944-8fc0-41df-bcb0-98378bb57601.pdf",
            "news_date": "2026-02-09 17:55:06",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cac5944-8fc0-41df-bcb0-98378bb57601.pdf",
            "news_date": "2026-02-09 17:55:06"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": " Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
            "news_body": "Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015- Conclusion of Search by GST Authorities",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09391bce-5ddc-4620-a773-9f36478a4979.pdf",
            "news_date": "2026-02-09 17:34:32"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Publication of Unaudited Standalone & Consolidated Financial Results for the Quarter and Nine Months ended 31-12-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=553ed99f-c5e3-47c0-b3b9-4bd119711688.pdf",
            "news_date": "2026-02-04 12:30:40"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call on Unaudited Standalone and   Consolidated Financial Results for the Quarter and Nine Months Ended 31st December 2025",
            "news_id": "9215d8ed-62b1-42ae-8d9c-581a62be4c1f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac6929d2-2815-4901-aebd-89ba65830fdd.pdf",
            "news_date": "2026-02-03 18:47:47",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call on Unaudited Standalone and   Consolidated Financial Results for the Quarter and Nine Months Ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac6929d2-2815-4901-aebd-89ba65830fdd.pdf",
            "news_date": "2026-02-03 18:47:47"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Approval of Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December 2025",
            "news_id": "01ee5296-fedb-4914-9eb8-157d71cf0839",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ae8a8fe-19b3-4ba1-8b2b-607a8b7e4890.pdf",
            "news_date": "2026-02-03 12:04:56",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Approval of Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ae8a8fe-19b3-4ba1-8b2b-607a8b7e4890.pdf",
            "news_date": "2026-02-03 12:04:56"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 03/02/2026",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations\r\nand Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors\r\nof the Company at its Meeting held today i.e. 03rd February 2026 has inter-alia considered and\r\napproved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine\r\nMonths Ended 31st December 2025 along with the Limited Review Report with unmodified opinion\r\non the aforesaid Unaudited Financial Results.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5652c8d-1c67-4b43-9706-fa8189699fe5.pdf",
            "news_date": "2026-02-03 12:00:47"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015",
            "news_body": "Disclosure under Reg 30 of SEBI LODR-Intimation of visiting of GST Authorities for search",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a6a6fa6-de13-4acd-a9b1-15b3552da9f9.pdf",
            "news_date": "2026-02-03 11:13:58"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 this is to inform you that Nomination and Remuneration Committee in its meeting held today i.e. 03rd February 2026 has approved the allotment of 55700 Equity Shares of Face Value of Rs. 2 each to the Indoco Employees Welfare Trust as per Indoco Remedies Limited Employee Stock Option Plan 2022",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff53f677-ad15-4152-8d9e-c8d292595a3d.pdf",
            "news_date": "2026-02-03 09:39:54"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Indoco Remedies receives final ANDA approval from USFDA for Lacosamide Oral Solution USP10mg/mL",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e070f2ad-b83e-4bae-8119-5d8516505abb.pdf",
            "news_date": "2026-01-30 13:14:17"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earnings Conference Call on Unaudited Financial Results for Quarter and Nine Months Ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3ad7ade-2309-4bda-ac17-5c2b06526295.pdf",
            "news_date": "2026-01-20 11:32:34"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve The Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2025.\r\n\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6fceaa4-3eb1-40d5-ba70-8a21ddf8847e.pdf",
            "news_date": "2026-01-16 17:32:39"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ECF27633_EF60_4C02_B8EF_3B5D0D7A12E9_172651.pdf",
            "news_date": "2026-01-13 17:26:59"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Attached Certificate issued by MUFG Intime India Pvt Ltd Registrar & Transfer Agent of the Company confirming compliance under Regulation 74(5) of SEBI (D&P) Regulations2018 for the qtr ended 31-12-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86e58de6-e44c-422e-986b-a3a864255435.pdf",
            "news_date": "2026-01-06 18:09:49"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=602C8017_539D_4F2E_A857_8934242C3783_095731.pdf",
            "news_date": "2025-12-31 10:36:30"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust & Other",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82D3165A_EE80_4CD4_BB07_D77EEEDC84B0_095221.pdf",
            "news_date": "2025-12-31 10:35:21"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66903975-2ca5-42a2-9c15-ba4ce1c9925e.pdf",
            "news_date": "2025-12-30 19:12:02"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the  senior management of the Company shall be meeting analysts/investors on 18th  February 2026 at Dolat Capital Corporate Conference 2026 - Decoding Growth Strategies",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4dfd0f95-5b34-4274-af2a-357ca06bdc8c.pdf",
            "news_date": "2025-12-29 22:29:41"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011",
            "caption": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C11C3F56_8F42_48BD_8AF2_4AC829D959D0_102351.pdf",
            "news_date": "2025-12-19 10:24:03"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=394DECC1_10DF_49E0_AA08_3C05797BAD00_182014.pdf",
            "news_date": "2025-12-15 18:20:22"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release regarding receipt of Establishment Inspection Report from the USFDA for the Companys API manufacturing facility located at Patalganga",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05c918a0-f104-4949-b8d1-bb7510976da4.pdf",
            "news_date": "2025-12-11 17:44:05"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Retirement Of Senior Management Personnel",
            "news_body": "We hereby inform you that Mr. Ajay Karajagi (President -Sales & Marketing) designated as Senior Management Personnel of the Company shall retire from the Company w.e.f close of business hours on 30-11-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f28fd6c-4c96-4c47-99ec-30147b65cfd3.pdf",
            "news_date": "2025-11-28 16:40:04"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91F8B4B2_3D27_4943_9EF4_534CC7565A4D_134906.pdf",
            "news_date": "2025-11-28 13:49:10"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33FDE566_90B9_48CE_B2D9_4D6A6E957CDB_124642.pdf",
            "news_date": "2025-11-28 12:46:46"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 2011",
            "caption": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Kare Family Pvt Trust & Aruna Suresh Kare",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09071590_CAFE_471A_B4DE_BE0671BF2D2A_125252.pdf",
            "news_date": "2025-11-18 12:49:30"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed Transcript of Earnings Conference Call held on 06-11-2025 in respect of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2025",
            "news_id": "739cd73e-bc72-4983-ae85-b57c16d6d970",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1ef7d09-04d9-46ff-a7b5-c404da807dab.pdf",
            "news_date": "2025-11-10 14:22:06",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed Transcript of Earnings Conference Call held on 06-11-2025 in respect of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1ef7d09-04d9-46ff-a7b5-c404da807dab.pdf",
            "news_date": "2025-11-10 14:22:06"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Publication of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended 30-09-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=122f2586-eb8c-473c-b600-1f0ec860810e.pdf",
            "news_date": "2025-11-07 10:52:23"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call on unaudited Standalone & Consolidated Financial Results for the quarter and half year ended 30-09-2025",
            "news_id": "7366e4ce-f7d3-4e48-9528-6fe7a98570f2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4df9b3a6-57c0-4e70-a809-49417676ceb3.pdf",
            "news_date": "2025-11-06 19:30:53",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call on unaudited Standalone & Consolidated Financial Results for the quarter and half year ended 30-09-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4df9b3a6-57c0-4e70-a809-49417676ceb3.pdf",
            "news_date": "2025-11-06 19:30:53"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Approval of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September 2025",
            "news_id": "455cd40c-292d-49ac-b6cf-f02565be7cfc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f5792e5-40e1-415d-acd5-ce82e628d347.pdf",
            "news_date": "2025-11-06 11:37:06",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Approval of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f5792e5-40e1-415d-acd5-ce82e628d347.pdf",
            "news_date": "2025-11-06 11:37:06"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th November 2025",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 06th November 2025 has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September 2025 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e66af61e-93e8-4631-ab76-26464ce12b68.pdf",
            "news_date": "2025-11-06 11:33:13"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -Corporate Guarantee For Warren Remedies Private Limited Wholly Owned Subsidiary Of The Company",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we would like to inform you that the Committee of Executive Directors at its meeting held on 29-10-2025 approved the Corporate Guarantee upto a maximum principal amount of Rs. 25 Crores in favour of HDFC Bank limited in respect of the Loan/Credit Facilities to be availed in tranches by Warren Remedies Private Limited wholly owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cba25755-1adf-4f6a-b89e-9f301d212b36.pdf",
            "news_date": "2025-10-29 11:08:53"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation regarding 100 days campaign \"Saksham Niveshak\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c502158-8153-482c-9850-2c269e9126cd.pdf",
            "news_date": "2025-10-18 12:33:24"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earnings Conference Call on Unaudited Financial Results for quarter and half year ended 30-09-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c58e9a7a-f689-43fb-bc20-1bb3686f52a3.pdf",
            "news_date": "2025-10-17 14:52:21"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": " Clarification To BSE- Movement In Volume",
            "news_body": "Clarification with reference to Movement in Volume Letter of BSE dated 14th October 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2efbe0d5-9eaf-4c16-ae94-81cbe112809c.pdf",
            "news_date": "2025-10-14 13:58:22"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Indoco Remedies Ltd",
            "news_body": "The Exchange has sought clarification from Indoco Remedies Ltd on October 14 2025 with reference to Movement in Volume<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-10-14 11:27:01"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting Under Reg 29 Of SEBI (LODR) Regulations 2015",
            "news_body": "Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve The unaudited standalone & consolidated financial results of the Company for the quarter and half year ended 30-09-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bc2762c-b0ea-4036-9967-682ecced76e2.pdf",
            "news_date": "2025-10-14 11:21:27"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Attached certificate issued by MUFG INTIME INDIA PVT LTD  Registrar & Transfer Agent of the Company confirming compliance under Reg 74(5) of SEBI (DP)Regulations2018 for the quarter ended 30-09-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b8df8bc-9e9f-438b-b551-69528300d3cd.pdf",
            "news_date": "2025-10-10 19:02:19"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f1d325e-a31a-4975-a0a2-dcc6b98f7ab8.pdf",
            "news_date": "2025-09-30 12:26:27"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation of Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09018941-ae04-4859-a2d0-c7970687039e.pdf",
            "news_date": "2025-09-25 11:55:30"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (LODR) Regulation 2015 we wish to inform you that the senior management of the Company shall be meeting  analyst/investor through virtual meet on 25-09-2025 at 02.00 pm.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=415cab54-38c2-4718-a853-01e6b7ce204b.pdf",
            "news_date": "2025-09-19 15:16:52"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release- USFDA successfully completes inspection at Indocos API manufacturing facility at Patalganga with zero observations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8a4bebc-58f8-45fd-937f-c42ab9301a5d.pdf",
            "news_date": "2025-09-19 14:36:23"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Please find enclosed the details of Voting Results & Scrutinizers Report for the 78th AGM of the Company held on 11th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6f6db2e-c243-4557-9bed-9317233dbdc9.pdf",
            "news_date": "2025-09-12 15:43:49"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "We are submitting herewith the details regarding the Proceedings of the 78th AGM of the Company held on Thursday 11th September 2025 at 10.30 am through video conferencing (VC)/other audio video means (OAVM)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9962f76f-1744-4967-ac97-91c2d129eb5e.pdf",
            "news_date": "2025-09-11 12:54:49"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Memorandum of Understanding /Agreements",
            "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
            "news_body": "We wish to inform you that the Company has entered into a Sale Agreement & Lease Agreement on 29th August 2025 for sale & lease back of part of the Companys movable properties at it Waluj Facility and CRO",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0be07940-f2e1-4b32-83f2-db2adb24cdf6.pdf",
            "news_date": "2025-08-30 10:27:05"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (LODR) Regulation 2015 we wish to inform you that the senior management of the Company shall be meeting analysts/institutional investors on 05-09-2025 at 12.00 noon.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=851b4485-1eb0-4200-8e44-dbb8bea92eef.pdf",
            "news_date": "2025-08-29 12:39:19"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement regarding Notice convening the 78th  AGM and E-voting information",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ccf661a-1496-4995-9a5e-0083b55c28a0.pdf",
            "news_date": "2025-08-15 15:03:30"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b7b4ef0-04db-47f7-b2d8-1f610c5dafad.pdf",
            "news_date": "2025-08-14 16:18:48"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the financial year 2024-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d93ac49f-202a-4978-b50e-fa27eb241cf6.pdf",
            "news_date": "2025-08-14 16:16:33"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 78Th Annual General Meeting And Annual Report For The Financial Year 2024-25",
            "news_body": "Notice of 78th Annual General Meeting and Annual Report for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a4ce25f-c5cb-486e-927d-82e5f87f9510.pdf",
            "news_date": "2025-08-14 16:08:24"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Cut-Off Date For E-Voting Book Closure And Record Date For Dividend",
            "news_body": "Intimation of Cut -off date for E-Voting Book Closure and Record Date for Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba680c13-93a0-43b5-b4a7-9462c105989e.pdf",
            "news_date": "2025-08-14 15:41:47"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "We are pleased to inform the final approval of the Companys Abbreviated New Drug Application (ANDA) for Rivaroxaban Tablets USP from USFDA.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f588577-9feb-40b6-8f97-3ec6f7af5014.pdf",
            "news_date": "2025-08-13 09:51:55"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Publication of Newspaper Advertisement pursuant to MCA Circulars of 78th AGM of the Company to be held on 11th September 2025 through VC/OAVM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f47c4d43-8f6a-4452-a2fd-9b9b95e392ff.pdf",
            "news_date": "2025-08-09 13:58:44"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=F7472061_77CF_4873_8B43_F5B46162DA10_171441.pdf",
            "news_date": "2025-08-08 17:14:53"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation of Revision in Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a0f8370-a34d-4097-9b35-fd9c46b0f907.pdf",
            "news_date": "2025-08-04 17:07:51"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Memorandum of Understanding /Agreements",
            "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
            "news_body": "We wish to inform you that Company has entered into a Sale Agreement & Lease Agreement on 31st July2025 for sale and lease back of part of the Companys movable properties at its Waluj Facility.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=886dd0ee-ac88-4607-8a88-783bcf720fe9.pdf",
            "news_date": "2025-08-01 15:28:26"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (LODR) Regulation 2015 we wish to inform you that the senior management of the Company shall be meeting analyst/investor through virtual meet on 11-08-2025 at 10.00 am.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55253a8a-74d4-4877-a984-8fb6fca830eb.pdf",
            "news_date": "2025-07-30 14:19:51"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed Transcript of Earnings Conference Call held on 24-07-2025 in respect of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2025.",
            "news_id": "3d8fe148-3b73-46e8-ac85-d21b4d66deb2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99a1bb23-7f1b-414c-9ba7-af6b0b0c6b90.pdf",
            "news_date": "2025-07-28 11:38:02",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Enclosed Transcript of Earnings Conference Call held on 24-07-2025 in respect of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99a1bb23-7f1b-414c-9ba7-af6b0b0c6b90.pdf",
            "news_date": "2025-07-28 11:38:02"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Unaudited Standalone and consolidated Financial Results for the quarter ended 30-06-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c8a7bde-8756-4df8-8e44-33ece893b682.pdf",
            "news_date": "2025-07-25 12:52:25"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call on Unaudited Standalone & Consolidated Financial Results for the quarter ended 30-06-2025",
            "news_id": "87957e88-d1f7-49dd-b02d-f0b283be0e27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c2a8888-f8c9-4bb4-a106-86ba02159c68.pdf",
            "news_date": "2025-07-24 18:11:57",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call on Unaudited Standalone & Consolidated Financial Results for the quarter ended 30-06-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c2a8888-f8c9-4bb4-a106-86ba02159c68.pdf",
            "news_date": "2025-07-24 18:11:57"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Approval of Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2025 along with Limited Review Report",
            "news_id": "40754531-1954-4fde-b229-91d19ec27d6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f8e8b6a-e757-4bd9-a3d1-589f78c9173c.pdf",
            "news_date": "2025-07-24 12:02:41",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Approval of Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2025 along with Limited Review Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f8e8b6a-e757-4bd9-a3d1-589f78c9173c.pdf",
            "news_date": "2025-07-24 12:02:41"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 24Th July 2025",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 24th July 2025 has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2025 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dc2b629-98e9-4156-8a1f-f1ac347f4d98.pdf",
            "news_date": "2025-07-24 11:59:17"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Indoco Remedies Limited receives Certificate of EU GMP Compliance from the European Health Authorities for the sterile drug product manufacturing facility Goa Plant II",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a04759c-e2e6-482d-bf54-1920cbb1711c.pdf",
            "news_date": "2025-07-24 09:18:44"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earnings Conference Call on Unaudited Financial Results for quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28c3062d-84f6-4647-89c7-3b8c4409dc79.pdf",
            "news_date": "2025-07-16 12:10:26"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for  Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30-06-2025.",
            "news_body": "Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2025 inter alia to consider and approve  Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended 30-06-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91139715-b4fe-48c3-bf54-10cb3f673128.pdf",
            "news_date": "2025-07-14 17:46:29"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Attached certificate issued by MUFG Intime India Pvt Ltd Registrar & Transfer Agent of the Company confirming compliance under Regulation 74(5) of SEBI (D&P)Regulations2018 for the quarter ended 30-06-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef218fc6-fca8-4a43-bca7-a0ed62a413d2.pdf",
            "news_date": "2025-07-09 18:07:48"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the senior management of the Company shall be meeting analysts/institutional investors in a physical group meeting at the Ashwamedh-Elara India Dialogue 2025 to be held on 03-09-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7cf477b-f86c-4efd-b643-b9b796d4e990.pdf",
            "news_date": "2025-07-03 16:43:05"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the senior management of the Company shall be meeting analysts/institutional investors in a physical group meeting at the Antique Investor Conference to be held on 21st August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0be303f2-a776-42b3-9d4c-fa40a386d5cd.pdf",
            "news_date": "2025-07-03 16:38:05"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the senior management of the Company shall be meeting analysts/institutional investors in a physical group meeting at the Emkay Confluence to be held on 13th August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1be56922-4b96-4900-b091-ee58dd806b68.pdf",
            "news_date": "2025-07-03 16:33:26"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding Closure of Trading Windows",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=177f26de-9054-42f1-9edc-1994814625df.pdf",
            "news_date": "2025-06-27 15:53:58"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN KYC And Bank Details As Per SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 Dated May 07 2024 And SEBI Circular Bearing Reference No. SEBI/HO/MIRSD",
            "news_body": "Pursuant to Regulation 30 and Part A of Schedule III of SEBI (LODR) Regulations2015 please find enclosed a copy of the letter dispatched to the shareholders holding shares in physical mode in compliance with the SEBI Circular no SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated 07-05-2024 & Circular no. SEBI/HO/MIRSD-PoD-1/P/CIR/2024/81 dated 10-06-2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3df8a658-b437-42bd-9d2c-b11d8a687f73.pdf",
            "news_date": "2025-06-24 14:58:07"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Notice for Transfer of equity shares of the Company to the Investor Education & Protection Fund (IEPF).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aca57fa0-ea36-4e9f-9e16-336b77837b3c.pdf",
            "news_date": "2025-06-19 15:36:12"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation regarding Notice from GST Authority",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d448de8-97da-41c8-8663-2e76684fa221.pdf",
            "news_date": "2025-06-13 13:57:22"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 (LODR):- Order For Drop Of Proceeding Under GST Act 2017",
            "news_body": "The Company has received an Order from GST Authority for drop of proceeding under section 61 of GST Act 2017 against the Notice dated 07th February 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=732b1d32-4d6e-43ee-af62-61c9f5adb02e.pdf",
            "news_date": "2025-06-12 21:34:17"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the senior management of the Company shall be meeting analysts/institutional investors on 17th June 2025 at 04.00 pm.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d5f52e4-ed78-4862-9790-24bdfdf36570.pdf",
            "news_date": "2025-06-12 12:39:05"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Order For Drop Of Proceeding",
            "news_body": "The Company has received an Order from GST Authority for Drop of proceedings under Section 61 of GST Act2017 against the Notice dated 07-02-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10662924-22e6-494f-9591-942fe58821b1.pdf",
            "news_date": "2025-06-11 16:27:56"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Indoco Remedies UK Limited the subsidiary of our Company has officially launched Ticagrelor film-coated tablets 90mg in the United Kingdom.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8d4cacb-bfe8-4bfb-aaf1-235b8ab83408.pdf",
            "news_date": "2025-06-03 13:02:02"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Enclosed the Annual Secretarial Compliance Report dated                  22-05-2025 for the FY 2024-25 issued by our secretarial auditor CS Ajit Sathe Proprietor of M/s. A Y Sathe & Co Company Secretaries.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cb76d8d-c947-40c0-90ba-48d94825bb64.pdf",
            "news_date": "2025-05-27 15:45:44"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call on Audited Standalone and Consolidated Financial Results for the quarter and year ended 31-03-2025",
            "news_id": "00ac6816-ab11-4ce7-bf3e-3faad13a9019",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50baf8c6-216f-420a-819e-be8049be3653.pdf",
            "news_date": "2025-05-26 12:38:48",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call on Audited Standalone and Consolidated Financial Results for the quarter and year ended 31-03-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50baf8c6-216f-420a-819e-be8049be3653.pdf",
            "news_date": "2025-05-26 12:38:48"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Audited Standalone & Consolidated Financial Results for the quarter and year ended 31-03-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=427e4c86-c281-49d4-abb1-1f2d109ff3fc.pdf",
            "news_date": "2025-05-23 13:52:26"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the management of the Company will be meeting analysts/investors on 29-05-2025 at the B&K Securities 15th Annual Investor Conference - Trinity India 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eed7ec60-aa65-40c2-90f5-235611640fbb.pdf",
            "news_date": "2025-05-23 11:50:28"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200mg",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fb1ae0b-df85-48a9-8094-05d00271b8f0.pdf",
            "news_date": "2025-05-23 11:13:06"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call on Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March 2025",
            "news_id": "e67b1f15-89aa-4756-b728-a023fa01cfcc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ae361ec-4fab-42f5-b891-43d48d9be285.pdf",
            "news_date": "2025-05-22 19:28:28",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call on Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ae361ec-4fab-42f5-b891-43d48d9be285.pdf",
            "news_date": "2025-05-22 19:28:28"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Secretarial Auditor And Internal Auditor Of The Company",
            "news_body": "Re-appointment of A.Y.Sathe & Co. as the Secretarial Auditor of the Company and Suresh Surana & Associates LLP as Internal Auditors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e805f1e-c1b5-44cc-bd2f-b5ac5634b38a.pdf",
            "news_date": "2025-05-22 14:40:36"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Re-appointment of Dr. Vasudha Kamat and Mr. Abhijit Gore as an Independent Directors of the Company for second term of five years subject to the approval of the shareholders.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc3f220b-b1d8-4930-904e-be4ca282f491.pdf",
            "news_date": "2025-05-22 14:38:29"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Year Ended 31St March 2025",
            "news_body": "Approval of Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March 2025",
            "news_id": "3f553475-d4f6-4d0b-b3f2-a64462635f89",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2266188-4c0b-47ad-925d-0f66bc75ae89.pdf",
            "news_date": "2025-05-22 14:36:04",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Year Ended 31St March 2025",
            "news_body": "Approval of Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2266188-4c0b-47ad-925d-0f66bc75ae89.pdf",
            "news_date": "2025-05-22 14:36:04"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Financial Results For The Year Ended 31St March 2025 And Recommendation Of A Final Dividend",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (\"Listing Regulations\") we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 22nd May 2025 has inter-alia considered and approved the following.1. Audited Financial Results (Consolidated and Standalone) for the quarter and year ended 31st March 2025 and Auditors Reports with unmodified opinion on the aforesaid Audited Financial Results.2. Subject to the approval of the Members at the ensuing 78th Annual General Meeting recommended a Dividend of Rs. 0.20 per equity share on face value of Rs. 2/- for the financial year 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77fc2c45-9817-49da-a866-50dee26bfc00.pdf",
            "news_date": "2025-05-22 14:32:00"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earnings Conference Call on Audited Financial Results for the Quarter and Year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f99e81d-4753-4c82-8e85-e8015bc9a2a7.pdf",
            "news_date": "2025-05-15 15:36:27"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earnings Conference Call on Audited Financial Results for quarter and  Year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f7f0e5f-62f5-4350-aad8-9e49bdee556c.pdf",
            "news_date": "2025-05-15 14:20:22"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Results & Dividend",
            "news_body": "Indoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 inter alia to consider and approve 1. The Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March 2025. 2. To recommend a final dividend if any for the financial year ending 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=758ca6dd-0dd0-4f41-8414-5ec15ce4eafc.pdf",
            "news_date": "2025-05-14 16:35:15"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Attached the Certificate issued by MUFG Intime India Pvt Ltd Registrar & Transfer Agent of the Company confirming compliance under Regulation 74(5) of SEBI (D&P) Regulations2018 for the quarter ended 31-03-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48279b64-d307-4b93-bccc-a61ae4490a16.pdf",
            "news_date": "2025-04-07 17:01:23"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=201149e6-46d7-44d2-8878-399364f66bc3.pdf",
            "news_date": "2025-03-28 12:13:27"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations2015 (Listing Regulations)",
            "news_body": "The Company has received an Assessment Order u/s 143(3) dated 26-03-2025 for Assessment year 2023-24 from Assessment Unit Income tax Department.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=651c4fc3-a442-4610-945d-0bb6dfe449d4.pdf",
            "news_date": "2025-03-27 10:46:34"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Code of Conduct under SEBI (PIT) Regulations 2015",
            "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
            "news_body": "In compliance with Regulation 8(2) of SEBI (PIT) Regulations2015 it is to inform that the Board of Directors of the Company in their meeting held on 25-03-2025 has adopted the revised Code of Conduct for Prevention of Insider Trading & Code of Practices and Procedures for Fair Disclosure of UPSI",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0776964a-afd2-4968-b169-10db417008ef.pdf",
            "news_date": "2025-03-25 11:36:18"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Appointment Of Cost Auditor Of The Company Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "The Board of Directors of the Company at their meeting held on 25-03-2025 has interalia considered and approved the following:\r\nReappointment of M/s. Joshi Apte & Associates Cost Accountants as the Cost Auditors of the Company for the financial year 2025-2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1353fce-f2d7-4b62-a525-917cc15a99cd.pdf",
            "news_date": "2025-03-25 11:29:50"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shanteri Investment Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2A6968D6_C642_4AEA_8600_2E1B99595697_105132.pdf",
            "news_date": "2025-03-21 10:51:37"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shanteri Investment Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8D10E1E5_ABB4_4BBC_B7B4_BD43318F6435_143721.pdf",
            "news_date": "2025-03-19 14:37:28"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 (6) read with Schedule III OF THE SEBI (LODR) Regulation 2015 we wish to inform you that the management of the Company will be meeting investors and analysts on 21-03-2025 at the 10th Annual Valorem Analyst Conference.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2922351-7436-413b-988d-b0110d855178.pdf",
            "news_date": "2025-03-12 13:01:01"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shanteri Investment Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10E4AE27_CD94_41AD_AB05_5628B3401597_105832.pdf",
            "news_date": "2025-03-12 10:58:36"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shanteri Investment Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E353E20A_E2D3_4A1B_9ECD_3CC2E25D1440_101219.pdf",
            "news_date": "2025-03-11 10:12:23"
        },
        {
            "co_code": 12579,
            "bse_code": 532612,
            "isin": "INE873D01024",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Indocos Clinical Research Organisation - AnaCipher completes US FDA inspection.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92ee5e9e-f950-4e9d-b5e4-093875297c31.pdf",
            "news_date": "2025-03-10 15:58:48"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31-12-2024.",
            "news_id": "07fac6b6-b50b-4ac9-b852-6629ce44e157",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=430d8b36-806b-4bd1-a9a8-ad9b46d4fc2e.pdf",
            "news_date": "2025-01-24 12:49:21",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2024",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2024",
            "news_id": "69e1b33d-e2f6-4844-b892-55aadf049e71",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6adca4f6-c7a7-4b22-88be-cd1c1cf91256.pdf",
            "news_date": "2025-01-21 12:28:25",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2024",
            "news_id": "2d8b23c1-22d5-4099-b511-bcba60fef641",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93ffb66b-6af1-442b-ba0c-e411ae33ff5a.pdf",
            "news_date": "2024-10-28 13:10:48",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended  30th September, 2024 held today i.e. 24th October, 2024 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.30 p.m. (IST) on 24th October, 2024.",
            "news_id": "07727cf8-1f91-46c0-9e52-241c753708b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=212ceada-6a1f-4d0c-b6fd-4003a8223a64.pdf",
            "news_date": "2024-10-24 18:46:55",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Investor Presentation on Financial Results for the Quarter and Half Year ended 30th September, 2024",
            "news_id": "21d3c880-f3ff-47f8-8f3e-383680309280",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca194bcf-baf8-48e0-9930-b79c57f2487d.pdf",
            "news_date": "2024-10-24 15:26:13",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September, 2024",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2024",
            "news_id": "4da62f1d-7fd3-4de8-ab1e-dd8151c2b9f3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b9f5a52-370d-4b8d-b0f7-adfd9b3ed61e.pdf",
            "news_date": "2024-10-24 12:29:23",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2024",
            "news_id": "2c85803d-8727-4156-af80-deb6ed28f7bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d5a3d0a-5ec3-4580-9a68-1b0550b23047.pdf",
            "news_date": "2024-07-26 13:28:21",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2024 held today i.e. 24th July, 2024 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.25 p.m. (IST) on 24th July, 2024.",
            "news_id": "a5eeab33-2006-4556-b74d-d8df575a1b1b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1b93fa8-6823-4d5a-acc2-f12533bc5ab3.pdf",
            "news_date": "2024-07-24 18:20:55",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th June, 2024",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2024 along with Limited Review Report",
            "news_id": "b64cf18c-dff9-4512-b451-fab2ea7a8bea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ab2cdb9-a123-4ad1-be4f-c567534425cb.pdf",
            "news_date": "2024-07-23 11:13:20",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Enclosed a copy of Investor Presentation of the Company that will be shared with the various investors/Analysts.",
            "news_id": "96f989ed-ab74-447c-b8f2-2a73e4a92da3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e71e45d3-9ee6-4679-b314-ff2bbdc7bdae.pdf",
            "news_date": "2024-06-10 17:16:24",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations,2015, enclosed the transcript of Earnings Conference Call held on 16-05-2024 at 03.30 pm(IST).",
            "news_id": "53384a4e-a44b-42ea-9af3-2bfd3e0aebba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3df26b7-2a2b-46c5-b573-04046da47952.pdf",
            "news_date": "2024-05-21 11:13:32",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2024 held today i.e. 16th May, 2024 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.20 p.m. (IST) on 16th May, 2024.",
            "news_id": "9f6eb50c-bdea-4aee-b3ab-b79739e7de85",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f296e224-fd65-49ec-b6fb-62884067b606.pdf",
            "news_date": "2024-05-16 18:15:26",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended 31St March, 2024",
            "news_body": "Approval of Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2024",
            "news_id": "419163c5-f8b6-4b21-ae15-64221ce2a42d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd9444dc-b780-4102-9512-6180bce30515.pdf",
            "news_date": "2024-05-16 14:44:58",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of SEBI(LODR) Regulations, please find enclosed the transcript of Earnings Conference Call held on 23rd January, 2024 at 03:30 p.m.",
            "news_id": "ed56e8b8-f5cc-4f7d-8b7c-f309677d4bd6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82c46e1e-65c5-448c-aba8-2576760af1f9.pdf",
            "news_date": "2024-01-25 15:58:16",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended 31st December, 2023 held today i.e. 23rd January, 2024 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 4.25 p.m. (IST) on 23rd January, 2024",
            "news_id": "081989c6-637b-4e1d-8d0e-51f5977ac6cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30f31d3c-be67-4134-b062-4ead6cb9c085.pdf",
            "news_date": "2024-01-23 18:15:49",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December, 2023",
            "news_body": "Approval of Unaudited Financial Results for the Quarter and Nine months ended 31st December, 2023",
            "news_id": "32c0a0c9-0ae3-47ec-a6a2-51ccb201789c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7a7107e-89ae-4a38-9dd3-4c1d500ff0f0.pdf",
            "news_date": "2024-01-23 12:29:35",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call on Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30-09-2023",
            "news_id": "ca1ed5b5-4836-493b-9a70-2faf781a4397",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d892cc99-53a3-418f-b6d9-96c98185803d.pdf",
            "news_date": "2023-10-23 15:22:29",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call on Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023",
            "news_id": "60248d8c-8a52-486a-815b-df5b25b210ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1db904d5-d5c9-409b-8001-255ee698331c.pdf",
            "news_date": "2023-10-19 18:31:08",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Half Year Ended 30Th September, 2023",
            "news_body": "Approval of Unaudited Standalone and Consolidated Financial Results for the Quarter and Half year ended 30th September, 2023",
            "news_id": "c288b7c2-17eb-4d2e-83ea-fa7fdbd44047",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a4c0300-4652-4c9f-877b-a32bbce33913.pdf",
            "news_date": "2023-10-19 12:12:46",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III of the SEBI (LODR), Regulations, 2015, please find enclosed the transcript of Earnings Conference Call held on 25-07-2023 at 03:30 pm (IST) in respect of Unaudited Standalone & Consolidated Financial Results for the Qtr ended 30.06.2023.",
            "news_id": "d8424ccb-51ea-464f-badb-50bb6104bfa2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af9a3d68-f951-4f70-8170-5fc4e1770b76.pdf",
            "news_date": "2023-07-28 10:51:13",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2023 held today i.e. 25th July, 2023 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04:15 p.m. (IST) on 25th July, 2023.",
            "news_id": "f9bb7408-e929-449e-8e49-9c5afe3ee651",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2079745c-33fb-4005-8e13-435a5eeca72b.pdf",
            "news_date": "2023-07-25 18:21:15",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2023",
            "news_body": "Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we attach herewith the Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2023",
            "news_id": "2ee376ca-c2f2-40c4-84d9-677b6e4a958e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80a4aeab-769f-4e3c-a0f3-1f5fb8440692.pdf",
            "news_date": "2023-07-25 11:45:05",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th July, 2023",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 25th July, 2023 has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2023 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.",
            "news_id": "9c2fb0df-6632-4703-adcf-7bf8859b9870",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6018abf8-5b2c-4b7d-8999-d613f432fced.pdf",
            "news_date": "2023-07-25 11:39:42",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is to inform you that an Earnings Conference Call on Unaudited Financial Results for the quarter ended 30-06-2023 is scheduled to be held on Tuesday, 25-07-2023 at 03:30 P.M. IST.",
            "news_id": "9e631f8a-7959-42f5-9079-7250c8637746",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=829442ed-3a03-4db7-ad17-545ca201c796.pdf",
            "news_date": "2023-07-18 15:41:47",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,  enclosed the transcript of Earnings Conference Call held on 23rd May, 2023 in respect of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2023.",
            "news_id": "9fa058a2-6669-4d94-b6ca-11ccb8186cb8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c24f9994-d11b-4282-aa30-fce1a420e686.pdf",
            "news_date": "2023-05-26 15:37:34",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of earnings conference call for the quarter and year ended 31st March 2023",
            "news_id": "caf0af97-913a-4390-afdb-b5b88afccf48",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5fd7b7f-4909-432a-a97d-8c2f526da01d.pdf",
            "news_date": "2023-05-23 19:22:47",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended 31St March 2023",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (Listing Regulations), we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 23rd May, 2023 has  considered and approved <BR> the Audited Financial Results (Consolidated and Standalone) for the quarter and year ended 31st March, 2023 and Auditors' Reports with unmodified opinions on the aforesaid Audited Financial Results.",
            "news_id": "acf81b4b-e39a-4a35-a012-e3da118d1672",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0bc0957-ffcc-4034-b44d-d1c278ed7cc9.pdf",
            "news_date": "2023-05-23 13:38:15",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 23Rd May, 2023",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (Listing Regulations), we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 23rd May, 2023 has inter-alia considered and approved the following.<BR> 1. Audited Financial Results (Consolidated and Standalone) for the quarter and year ended 31st March, 2023 and Auditors' Reports with unmodified opinions on the aforesaid Audited Financial Results.<BR> 2. Subject to the approval of the Members at the ensuing 76th Annual General Meeting, recommended a Dividend of Rs. 2.25 per equity share on face value of Rs. 2/- for the financial year 2022-2023.<BR>",
            "news_id": "11ffbc72-7aca-4f31-93e3-70006cc2df1f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=117baff2-7dae-4934-ba06-77e264ba8060.pdf",
            "news_date": "2023-05-23 13:34:52",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio/Video recording of Conference organised by Dolat Capital Market Private Limited",
            "news_id": "817553db-1864-4b31-9b56-e2b9f1f60bd9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=428d5f07-7bad-4714-af9d-d8f25149a4de.pdf",
            "news_date": "2023-02-21 14:12:03",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our letter dated 02nd February, 2023 regarding intimation of schedule of investor calls and pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (Listing Regulations), the Audio/Video recording of the Investors Conference Call organised by Nirmal Bang on 13th February, 2023 is available on the Company's website at https://www.indoco.com/inv-investor-analysts-meetings.asp",
            "news_id": "33c7fa0e-2cac-42f6-a345-751e0445771b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af1a4126-995a-4a00-b096-ca7e32a696af.pdf",
            "news_date": "2023-02-14 10:05:18",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call for the quarter and nine months ended 31st December, 2022",
            "news_id": "36cad1c0-d9e7-4b39-9311-e6bfc4d8d4da",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c411ea9-2b3a-4944-93f1-15e910a09438.pdf",
            "news_date": "2023-01-31 17:17:57",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of earnings conference call for the quarter and nine months ended 31st December, 2022",
            "news_id": "b8775971-18b1-458d-9712-0bdeb80aa10c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90f831d8-b47c-4aaf-becf-87d03ede6e53.pdf",
            "news_date": "2023-01-25 09:45:28",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31/12/2022",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (Listing Regulations), we hereby inform<BR> you that the Board of Directors of the Company at its Meeting held today i.e. 24% January, 2023 has inter-alia considered and approved the Unaudited Standalone and Consolidated<BR> Financial Results for the quarter and nine months ended 31st December, 2022 along with the Limited Review Report issued by the Statutory Auditor of the Company.",
            "news_id": "f5d084b4-a7b3-4b32-877e-39e7f7838c5c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43b954a9-d3ff-4b0a-bfb7-383dae0581dc.pdf",
            "news_date": "2023-01-24 12:07:22",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 24'' January, 2023",
            "news_body": "Pursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations<BR> and Disclosure Requirements), Regulations, 2015 (Listing Regulations), we hereby inform<BR> you that the Board of Directors of the Company at its Meeting held today i.e. 24% January,<BR> 2023 has inter-alia considered and approved the Unaudited Standalone and Consolidated<BR> Financial Results for the quarter and nine months ended 31st December, 2022 along with the<BR> Limited Review Report issued by the Statutory Auditor of the Company.",
            "news_id": "1671ace7-d22e-4dda-a29d-fcbad096c760",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=262fe1f0-1353-4662-994d-fd4d676b9946.pdf",
            "news_date": "2023-01-24 12:04:30",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ('Listing Regulations')",
            "news_body": "Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions for the half year ended 30.09.2022.",
            "news_id": "e1ee0ec8-3a56-4afc-9d36-f3aa5b14b847",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67d6bd21-44c2-4c51-9e11-265347e9d254.pdf",
            "news_date": "2022-11-24 11:55:53",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of analyst call held on 11th November, 2022 in respect of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2022.",
            "news_id": "700d9a21-85b1-42c7-928e-06596641938e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83349b7c-332f-4504-9fdf-26ba22bcc0a0.pdf",
            "news_date": "2022-11-17 18:23:44",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of Conference Call held on November 11, 2022",
            "news_id": "af528d1d-9f4d-474b-b5c0-6b7d5a6c527d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=969c736b-e774-493c-9875-f0177e6f6e52.pdf",
            "news_date": "2022-11-11 14:37:43",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended 30/09/2022",
            "news_body": "The Board of Directors at their meeting held today, have approved and taken on record the Standalone & Consolidated Unaudited financial results of the Company for the second quarter/half year ended 30.09.2022.<BR> Enclosed please find copies of the following:<BR> a) Standalone & Consolidated unaudited results as per Regulation 33 of SEBI (Listing Obligation<BR> and Disclosure Requirements) Regulations, 2015<BR> b) Limited Review Certificate issued by our Statutory Auditors M/s. Gokhale & Sathe, Chartered<BR> Accountants.<BR> c) Press Release.<BR> <BR>",
            "news_id": "ea569932-7cbb-488f-9903-06ca6f393602",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a79fc394-160c-420b-b7f4-058ca5700ff5.pdf",
            "news_date": "2022-11-10 11:38:25",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 10Th November, 2022",
            "news_body": "The Board of Directors at their meeting held today, have approved and taken on record the Standalone & Consolidated Unaudited financial results of the Company for the second quarter/half year ended 30.09.2022.<BR> Enclosed please find copies of the following:<BR> a) Standalone & Consolidated unaudited results as per Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015<BR> b) Limited Review Certificate issued by our Statutory Auditors M/s. Gokhale & Sathe, Chartered Accountants.<BR> c) Press Release.<BR> The meeting commenced at 10.45 am and concluded at 11.30 am.<BR>",
            "news_id": "1fe506f2-f3b0-453e-9da4-21828cd57699",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5280df9c-9774-4548-bbab-a76b6cdec2e0.pdf",
            "news_date": "2022-11-10 11:34:15",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of Conference Call held on August 09, 2022",
            "news_id": "6150d9b0-9163-44cb-9b09-fecaa5d85ba4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55e41f1f-7a06-4ada-bec7-aa1190333077.pdf",
            "news_date": "2022-08-10 08:18:47",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter Ended 30Th June 2022",
            "news_body": "Results for the Quarter ended 30th June 2022",
            "news_id": "47900938-dbb5-4239-bdef-475d5ce9f443",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8abe5b2f-bce3-4570-94a4-324377c1f3a6.pdf",
            "news_date": "2022-08-09 11:35:22",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR THE HALF YEAR ENDED 31.03.2022",
            "news_body": "DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR THE HALF YEAR ENDED 31.03.2022",
            "news_id": "18b12c08-4418-4ca3-b2d6-4ef2a3bb2ace",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6730e52b-1639-4889-9d17-fce0ddc15ede.pdf",
            "news_date": "2022-05-27 14:31:26",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of Conference Call held on May 17, 2022",
            "news_id": "6172d6ee-d520-4cb9-8381-19414ada8175",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b5a689a-3218-4a07-81c5-5dae91cc7636.pdf",
            "news_date": "2022-05-18 10:13:46",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio recording of Conference Call held on May 17, 2022",
            "news_id": "40b459b0-06f0-4046-b5d9-2f91028b0524",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a6ee16e-203d-4e49-a980-c12f5fd017c6.pdf",
            "news_date": "2022-05-17 19:18:42",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended 31St March, 2022",
            "news_body": "Pursuant to Regulation 33 of Listing Regulations, we enclose herewith the following:<BR> 1. Audited Standalone Financial Results of the Company, as per the IND AS for the quarter and year ended 31st March, 2022 along with Auditors' Report thereon;<BR> 2. Audited Consolidated Financial Results of the Company, as per the IND AS for the year ended 31st March, 2022 and auditors report thereon;<BR> 3. Copy of Press Release.",
            "news_id": "588cac5b-ceca-4294-a23e-a69ee695cbbf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f596fcb8-f166-4f62-8cd4-5321dafee0c0.pdf",
            "news_date": "2022-05-17 12:36:43",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 17Th May, 2022",
            "news_body": "We wish to inform that the Board of Directors of the Company at its meeting held today i.e. 17-05-2022 has interalia considered and approved the following:<BR> 1. Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial year ended 31st March, 2022 along with Statutory Auditors Report. <BR> 2. Subject to the approval of the Members at the ensuing 75th AGM, recommended a Dividend of Rs.2.25 per share (including a Special Dividend of Rs. 0.75) on face value of Rs. 2/- for the Financial year 2021-2022. <BR> 3. Subject to the approval of the Members at the ensuing 75th AGM, recommended the re-appointment of M/s Gokhale & Sathe, Chartered Accountants (Firm Registration No. 103264W) as the Statutory Auditors of the Company for the second term of five years commencing from Financial Year 2022-23. <BR> 4. Subject to the approval of the Members at the ensuing 75th AGM, approved the Employee Stock Option Scheme.",
            "news_id": "9ea5e8de-540a-4406-8405-d7aca196f872",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db51dfd7-82aa-4c0b-ad8c-2fc928ee535f.pdf",
            "news_date": "2022-05-17 12:34:13",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Conference Call held on February 02, 2022",
            "news_id": "c3d7a5f9-84de-4583-900a-0f2d28e23654",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41a49674-f3c1-4ca0-9343-cbafef0e2ff2.pdf",
            "news_date": "2022-02-02 19:12:45",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Results For The Quarter And Nine Months  Ended 31St December 2021",
            "news_body": "Unaudited Results for the Quarter and Nine months  ended 31st December 2021",
            "news_id": "f1a4606f-da0f-4160-a2c1-3da82e52b61e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42afad9e-04af-4554-a9b5-4b677f3311c9.pdf",
            "news_date": "2022-02-01 11:40:21",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions Pursuant To Reg 23(9) Of SEBI (LODR) Reg, 2015 (Listing Regulations)",
            "news_body": "Related party transactions pursuant to Reg 23(9) of SEBI (LODR) Reg, 2015 (Listing Regulations)",
            "news_id": "669ab8c9-6f0e-418b-ac95-1d35b07a64bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69a1468e-421a-45c7-90a3-88b022698f98.pdf",
            "news_date": "2021-11-15 17:57:51",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call Held On November 02, 2021",
            "news_body": "Audio recording of Conference Call held on November 02, 2021",
            "news_id": "cddfad05-7c48-4ba5-847d-076f168e4a81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05f70637-7c0c-4895-b265-c8d19ea3ff36.pdf",
            "news_date": "2021-11-03 17:07:41",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone And Consolidated Financial Results As On 30Th September 2021",
            "news_body": "Submission of Standalone and Consolidated Financial Results as on 30th September 2021",
            "news_id": "ea88674a-1667-4116-a58b-f0626f7e37f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=542b045d-1e4a-409e-93cf-3d0fb9975fdb.pdf",
            "news_date": "2021-11-02 12:14:32",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call Held On August 11, 2021",
            "news_body": "Audio recording of Conference Call held on August 11, 2021",
            "news_id": "8318bbdc-7154-4fa5-90cd-2845fb4f96e0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a70a1a2-ab82-451b-adec-04aff155d1b9.pdf",
            "news_date": "2021-08-11 18:57:42",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 30.06.2021",
            "news_body": "UNAUDITED FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 30.06.2021",
            "news_id": "6ae350e4-74c3-4438-9cef-30e8cd0b9032",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=065e35ba-ae12-403b-a3e4-af4ae4cc590a.pdf",
            "news_date": "2021-08-11 12:07:04",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Written Transcript of Conference Call held on May 25, 2021",
            "news_id": "73b749ee-c51a-45a9-ad81-7b684d81214c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a21291b-3197-4041-af02-2fd4067595f1.pdf",
            "news_date": "2021-06-04 11:44:22",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Announcement Under Reg 30 (LODR)  (Updates)",
            "news_body": "Link of Audio recording of Conference Call held on May 25, 2021",
            "news_id": "48372372-84e7-4dfc-ba93-fc67d06ef94c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e97f04ac-a487-42b4-8de5-725d51e97855.pdf",
            "news_date": "2021-05-25 19:43:42",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation  23(9) - Related Party Transactions",
            "news_body": "Related Party transactions",
            "news_id": "abf32aa2-e602-4fef-9551-c2526930d5cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b4a40f4-2ad2-461d-8d64-deb7949cad10.pdf",
            "news_date": "2021-05-25 19:29:35",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOCO",
            "disp": "Indoco Remedies",
            "bse_code": 532612,
            "isin": "INE873D01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 33 Of Listing Regulations - Financial Results",
            "news_body": "Audited Standalone Financial Results of the Company, as per the IND AS for  the quarter and year ended 31st March,2021  <BR> <BR> Audited Consolidated Financial Results of the Company, as per the IND AS for the year ended 31st March, 2021",
            "news_id": "9c3055aa-363b-4d82-b0f6-c03e854bb81d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc95ea2a-29c6-4b2e-97dd-87d5a2ee4cf3.pdf",
            "news_date": "2021-05-25 12:06:39",
            "seo": "indoco-remedies-ltd",
            "ltp": 204.93,
            "ch": -5.469999999999999,
            "pch": -2.5998098859315584,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11677,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}